alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2022202EN.01001101.xml

| 19.5.2022 | EN | Official Journal of the European Union | C 202/11 |
| --- | --- | --- | --- |

19.5.2022

EN

Official Journal of the European Union

C 202/11

---

State aid – Decision to raise no objections

(2022/C 202/07)

The EFTA Surveillance Authority raises no objections to the following state aid measure:

| Date of adoption of the decision | 28 January 2022 |
| --- | --- |
| Case No | 88047 |
| Decision No | 027/22/COL |
| EFTA State | Norway |
| Title | COVID-19 additional amendments to the aid scheme for undertakings suffering a substantial loss of turnover |
| Legal basis | Act on the temporary subsidy scheme for enterprises with a significant reduction in turnover after August 2020 |
| Type of measure | Scheme |
| Objective | Compensate losses and thereby limit the damage caused by the COVID-19 pandemic |
| Form of aid | Grants |
| Budget | NOK 3,512 billion |
| Intensity | 70–90 % |
| Duration | Until 30 June 2022 |
| Economic sectors | All sectors except for companies engaged in petroleum extraction and production, companies engaged in production, transmission, distribution and trade of electric power, financial institutions and companies whose main purpose is investment activities |
| Name and address of the granting authority | The Brønnøysund Register Centre |
| Brønnøysundregistrene |
| P.O. Box 900 |
| N-8910 Brønnøysund |
| NORWAY |

Date of adoption of the decision

28 January 2022

Case No

88047

Decision No

027/22/COL

EFTA State

Norway

Title

COVID-19 additional amendments to the aid scheme for undertakings suffering a substantial loss of turnover

Legal basis

Act on the temporary subsidy scheme for enterprises with a significant reduction in turnover after August 2020

Type of measure

Scheme

Objective

Compensate losses and thereby limit the damage caused by the COVID-19 pandemic

Form of aid

Grants

Budget

NOK 3,512 billion

Intensity

70–90 %

Duration

Until 30 June 2022

Economic sectors

All sectors except for companies engaged in petroleum extraction and production, companies engaged in production, transmission, distribution and trade of electric power, financial institutions and companies whose main purpose is investment activities

Name and address of the granting authority

The Brønnøysund Register Centre

Brønnøysundregistrene

P.O. Box 900

N-8910 Brønnøysund

NORWAY

The authentic text of the decision, from which all confidential information has been removed, can be found on the EFTA Surveillance Authority’s Internet: http://www.eftasurv.int/state-aid/state-aid-register/decisions/

---
#### § 1263.7 Duly organized requirement.

An applicant shall be deemed to be duly organized, as required by section 4(a)(1)(A) of the Bank Act (12 U.S.C. 1424(a)(1)(A)) and § 1263.6(a)(1), if it is chartered by a State or federal agency as a building and loan association, savings and loan association, cooperative bank, homestead association, insurance company, savings bank, or insured depository institution or, in the case of a CDFI applicant, is incorporated under State or tribal law.
Order filed, August 17, 2016.

In The

Fourteenth Court of Appeals

____________

NO. 14-16-00540-CV

____________

FELIX P. BABAUTA, Appellant

V.

DEBRA V. JENNINGS AND RALPAHELL V. WILKINS, Appellee

On Appeal from the 295th District Court

Harris County, Texas

Trial Court Cause No. 2012-23475

ORDER

The reporter’s record in this case was due August 08, 2016. See Tex. R. 

App. P. 35.1. The court has not received a request to extend time for filing the 

record. The record has not been filed with the court. Because the reporter’s record 

has not been filed timely, we issue the following order.

We order Karen DeShetler, the substitute court reporter, to file the record 

in this appeal within 30 days of the date of this order. 

PER CURIAM
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF MARK VII, INC. FOR THE SIX MONTHS ENDED JANUARY 03, 1998
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JAN-03-1998
<PERIOD-START>                             DEC-28-1996
<PERIOD-END>                               JUN-28-1997
<CASH>                                          10,491
<SECURITIES>                                         0
<RECEIVABLES>                                   66,434
<ALLOWANCES>                                     1,996
<INVENTORY>                                          0
<CURRENT-ASSETS>                                82,808
<PP&E>                                           9,048
<DEPRECIATION>                                   4,368
<TOTAL-ASSETS>                                  93,744
<CURRENT-LIABILITIES>                           59,740
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           497
<OTHER-SE>                                      32,454
<TOTAL-LIABILITY-AND-EQUITY>                    93,744
<SALES>                                              0
<TOTAL-REVENUES>                               310,791
<CGS>                                                0
<TOTAL-COSTS>                                  271,314
<OTHER-EXPENSES>                                33,902
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  94
<INCOME-PRETAX>                                  5,690
<INCOME-TAX>                                     2,390
<INCOME-CONTINUING>                              3,300
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     3,300
<EPS-PRIMARY>                                      .68
<EPS-DILUTED>                                      .68
        

</TABLE>
§ 330.4 Continuation of separate deposit insurance after merger of insured depository institutions. Whenever the liabilities of one or more insured depository institutions for deposits are assumed by another insured depository institution, whether by merger, consolidation, other statutory assumption or contract: ( a ) The insured status of the institutions whose liabilities have been assumed terminates on the date of receipt by the FDIC of satisfactory evidence of the assumption; and
( b ) The separate insurance of deposits assumed continues for six months from the date the assumption takes effect or, in the case of a time deposit, the earliest maturity date after the six-month period. In the case of time deposits which mature within six months of the date the deposits are assumed and which are renewed at the same dollar amount (either with or without accrued interest having been added to the principal amount) and for the same term as the original deposit, the separate insurance applies to the renewed deposits until the first maturity date after the six-month period. Time deposits that mature within six months of the deposit assumption and that are renewed on any other basis, or that are not renewed and thereby become demand deposits, are separately insured only until the end of the six-month period.
§ 308.523 Protective order. ( a ) A party or a prospective witness or deponent may file a motion for a protective order with respect to discovery sought by an opposing party or with respect to the hearing, seeking to limit the availability or disclosure of evidence.
( b ) In issuing a protective order, the ALJ may make any order which justice requires to protect a party or person from annoyance, embarrassment, oppression, or undue burden or expense, including one or more of the following: ( 1 ) That the discovery will not be conducted;
( 2 ) That the discovery will be conducted only on specified terms and conditions, including a designation of the time or place;
( 3 ) That the discovery will be conducted only through a method of discovery other than that requested;
( 4 ) That certain matters not be inquired into, or that the scope of discovery be limited to certain matters;
( 5 ) That discovery be conducted with no one present except persons designated by the ALJ;
( 6 ) That the contents of discovery or evidence be sealed or otherwise kept confidential;
( 7 ) That a deposition after being sealed be opened only by order of the ALJ;
( 8 ) That a trade secret or other confidential research, development, commercial information, or facts pertaining to any criminal investigation, proceeding, or other administrative investigation not be disclosed or be disclosed only in a designated way; or
( 9 ) That the parties simultaneously file specified documents or information enclosed in sealed envelopes to be opened as directed by the ALJ.
# C_2020123EN.01004401.xml

| 16.4.2020 | EN | Official Journal of the European Union | C 123/44 |
| --- | --- | --- | --- |

16.4.2020

EN

Official Journal of the European Union

C 123/44

---

Dangerous substances – List of authorisation decisions taken by the EEA EFTA States in accordance with Article 44(5) of Regulation (EU) No 528/2012 in the second half of 2018

(2020/C 123/11)

Subcommittee I on the free movement of goods

To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No 225/2013 of 13 December 2013, the EEA Joint Committee is invited to note the following lists concerning authorisation decisions adopted on the basis of Article 44(5) of Regulation (EU) No 528/2012 for the period 1 July–31 December 2018, at their meeting on 29 March 2019.

---

ANNEX

List of authorisation decisions

The following authorisation decisions in accordance with Article 44(5) of Regulation (EU) No 528/2012 have been taken in the EEA EFTA States during the period 1 July–31 December 2018:

| Biocidal Product Name | Union authorisation under Article 44(5) of Regulation (EU) No 528/2012 | Country | Date of decision |
| --- | --- | --- | --- |
| Ecolab Iodine PT3 Family | 32018R1258 | Iceland | 7.11.2018 |
| Ecolab Iodine PT3 Family | 32018R1258 | Liechtenstein | 12.11.2018 |
| Ecolab Iodine PT3 Family | 32018R1258 | Norway | 9.11.2018 |
| Hypred’s iodine based products | 32018R1261 | Iceland | 7.11.2018 |
| Hypred’s iodine based products | 32018R1261 | Liechtenstein | 6.11.2018 |
| Hypred’s iodine based products | 32018R1261 | Norway | 8.11.2018 |
| Quat-chem’s iodine based products | 32018R1287 | Iceland | 7.11.2018 |
| Quat-chem’s iodine based products | 32018R1287 | Liechtenstein | 12.11.2018 |
| Quat-chem’s iodine based products | 32018R1287 | Norway | 13.11.2018 |
| Prodhynet’s iodine based products | 32018R1288 | Iceland | 7.11.2018 |
| Prodhynet’s iodine based products | 32018R1288 | Liechtenstein | 8.11.2018 |
| Prodhynet’s iodine based products | 32018R1288 | Norway | 14.11.2018 |

Biocidal Product Name

Union authorisation under Article 44(5) of Regulation (EU) No 528/2012

Country

Date of decision

Ecolab Iodine PT3 Family

32018R1258

Iceland

7.11.2018

Ecolab Iodine PT3 Family

32018R1258

Liechtenstein

12.11.2018

Ecolab Iodine PT3 Family

32018R1258

Norway

9.11.2018

Hypred’s iodine based products

32018R1261

Iceland

7.11.2018

Hypred’s iodine based products

32018R1261

Liechtenstein

6.11.2018

Hypred’s iodine based products

32018R1261

Norway

8.11.2018

Quat-chem’s iodine based products

32018R1287

Iceland

7.11.2018

Quat-chem’s iodine based products

32018R1287

Liechtenstein

12.11.2018

Quat-chem’s iodine based products

32018R1287

Norway

13.11.2018

Prodhynet’s iodine based products

32018R1288

Iceland

7.11.2018

Prodhynet’s iodine based products

32018R1288

Liechtenstein

8.11.2018

Prodhynet’s iodine based products

32018R1288

Norway

14.11.2018

---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Mental Health Special Emphasis Panel, Building Translational Research in Integrative Behavioral Science.                    

*Date:*                         November 4, 2009.                    

*Time:*                         3 p.m. to 4 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call.)                    

*Contact Person:*                         Rebecca C Steiner, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd, Room 6149, MSC 9608, Bethesda, MD 20892-9608. 301-443-4525.                         *steinerr@mail.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training, National Institutes of Health, HHS)

Dated: September 29, 2009.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. E9-23976 Filed 10-5-09; 8:45 am]

BILLING CODE 4140-01-P
**Exhibit 32.1**

 

CERTIFICATIONPURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with theQuarterly Report on From 10-Q of SkyWest, Inc. (the “Company”) for thequarter ended March 31, 2008 as filed with the Securities and ExchangeCommission on the date hereof (the “Report”), I, Jerry C. Atkin, ChiefExecutive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, asadopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the bestof my knowledge:

 

(1)        TheReport fully complies with the requirements of Section 13(a) or 15(d) ofthe Securities Exchange Act of 1934; and

 

(2)        Theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

 
| /s/ Jerry C. Atkin      |   |
|-------------------------|--------|
|                    |   |
| Jerry C. Atkin          |   |
| Chief Executive Officer |   |
| May 9, 2008        |   |

 

This certificationaccompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Actof 2002 and shall not, except to the extent required by the Sarbanes-Oxley Actof 2002, be deemed filed by the Company for purposes of Section 18 of theSecurities Exchange Act of 1934, as amended.

 

Asigned original of this written statement required by Section 906 of theSarbanes-Oxley Act of 2002 has been provided to the Company and will beretained by the Company and furnished to the Securities and Exchange Commissionor its staff upon request.

 

----
§ 336.13 Penalties. ( a ) *Penalties under section 10(k) of the FDI Act.* A senior examiner of the FDIC who violates the post-employment restrictions set forth in § 336.12 shall be subject to the following penalties— ( 1 ) An order— ( i ) Removing such person from office or prohibiting such person from further participation in the affairs of the relevant insured depository institution or company (including a bank holding company or savings and loan holding company) that controls such institution for a period of up to five years, and
( ii ) Prohibiting any further participation by such person, in any manner, in the affairs of any insured depository institution for a period of up to five years; or
( 2 ) A civil monetary penalty of not more than $250,000; or
( 3 ) Both.
( b ) *Enforcement by appropriate Federal banking agency of hiring entity.* Violations of § 336.12 shall be enforced by the appropriate Federal banking agency of the depository institution, depository institution holding company, or other company at which the violation occurred, as determined under section 10(k)(6), which may be an agency other than the FDIC.
( c ) *Scope of prohibition orders.* Any senior examiner who is subject to an order issued under paragraph (a)(1) of this section shall, as required by 12 U.S.C. 1820(k)(6)(B), be subject to paragraphs (6) and (7) of section 8(e) in the same manner and to the same extent as a person subject to an order issued under section 8(e).
( d ) *Other penalties.* The penalties set forth in paragraph (a) of this section are not exclusive, and a senior examiner who violates the restrictions in § 336.12 may also be subject to other administrative, civil, or criminal remedies or penalties as provided by law.
42378.

#### HATTON v. WRIGHT.

Pannell, Judge.

1. Ordinarily questions of negligence, gross negligence, contributory negligence, and whose negligence was the proximate cause of an injury and related questions are for the jury alone, and the courts will decline to solve such questions by a decision on the general grounds of the motion for new trial except in plain, palpable and indisputable cases. *Brown v. Binns,*87 Ga. App. 485 (2) (74 SE2d 370).

2. If plaintiff’s negligence is equal to or greater than that of defendant, he cannot recover *(Christian v. Macon R.*&c. *Co.,*120 Ga. 314 (1) (47 SE 923)) for plaintiff must be less at fault than defendant before he can recover in case of mutual negligence. *Central R. & Bkg. Co. v. Newman,*94 *15Ga. 560 (21 SE 219); *Jester v. Bainbridge State Bank,*4 Ga. App. 476 (2) (61 SE 929).

*Frankum, J., concurs. Felton, C. J., concurs in judgment.*

Submitted October 4, 1966

Decided January 11, 1967.

*Jones & Kemp, Charles M. Jones, J. Max Cheney,*for appellant.

*Sharpe, Sharpe & Hartley, T. Malone Sharpe,*for appellee.

3. The evidence in the present case authorized a finding by the jury that the deceased and defendant were traveling together and riding separate motorcycles along one side of a two-lane highway, the deceased riding about 15 or 20 feet ahead of the defendant and laterally about 4 feet to the defendant’s left, that deceased suddenly turned to the right and into the defendant’s path without warning for the purpose of turning onto another highway, that in spite of defendant’s efforts to prevent it, a collision occurred between the two motorcycles resulting in the death of the deceased. The jury was also authorized to find that the deceased and the defendant were equally negligent and that this equal negligence was the sole proximate cause of the injury and the death; and this is true even though the defendant testified the collision would not have occurred if he had not been traveling too closely behind the deceased. It follows, therefore, that the trial judge did not err in overruling the motion for new trial, which was based solely on the general grounds, nor did he err in overruling the motion for judgment non obstante veredicto.

*Judgment affirmed.*
§ 34.214 Ownership limitations for State-registered appraisal management companies. ( a ) *Appraiser certification or licensing of owners.* ( 1 ) An AMC subject to State registration pursuant to § 34.213 shall not be registered by a State or included on the AMC National Registry if such AMC, in whole or in part, directly or indirectly, is owned by any person who has had an appraiser license or certificate refused, denied, cancelled, surrendered in lieu of revocation, or revoked in any State for a substantive cause, as determined by the appropriate State appraiser certifying and licensing agency.
( 2 ) An AMC subject to State registration pursuant to § 34.213 is not barred by paragraph (a)(1) of this section from being registered by a State or included on the AMC National Registry if the license or certificate of the appraiser with an ownership interest was not revoked for a substantive cause and has been reinstated by the State or States in which the appraiser was licensed or certified.
( b ) *Good moral character of owners.* An AMC shall not be registered by a State if any person that owns more than 10 percent of the AMC— ( 1 ) Is determined by the State appraiser certifying and licensing agency not to have good moral character; or
( 2 ) Fails to submit to a background investigation carried out by the State appraiser certifying and licensing agency.